Maude Monthly: Insulet Omnipod Lots Outside of Recall Appear to Be Showing Same Defects; Medline Reports Thousands of Backlogged Reports; ConvaTec Subsidiary Discloses Hundreds of Deaths but Little Investigation of Their Causes

Adverse-event reports for Insulet Corporation’s (PODD) Omnipod 5 insulin pump that describe the specific defect behind two recalls earlier this spring reached an all-time monthly high in July, according to a Capitol Forum analysis of the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database…